Potent enzyme inhibitors derived from dromedary heavy-chain antibodies: EMBO J.

Download
  1. Get@NRC: Potent enzyme inhibitors derived from dromedary heavy-chain antibodies: EMBO J. (Opens in a new window)
AuthorSearch for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for:
TypeArticle
Journal titleEMBO J.
Volume17
Issue13
Pages35123520; # of pages: 9
SubjectACTIVE-SITE; alpha-Amylases; Amino Acid Sequence; Animals; antagonists & inhibitors; Antibodies; antibody; Antibody Affinity; Antibody Specificity; assay; Blood; Camels; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cattle; CHAIN; CHAINS; classification; DOMAIN; ENZYME; Enzyme Inhibitors; enzymes; Escherichia; Escherichia coli; ESCHERICHIA-COLI; genetics; Humans; Immunization; Immunoglobulin Heavy Chains; Immunoglobulin Variable Region; immunology; INHIBITOR; INHIBITORS; isolation & purification; Light; Male; metabolism; Mice; Molecular Sequence Data; POTENT; protein; Proteins; Recombinant Fusion Proteins; REGION; Sequence Alignment; SITE; Swine; synthetic
AbstractEvidence is provided that dromedary heavy-chain antibodies, in vivo-matured in the absence of light chains, are a unique source of inhibitory antibodies. After immunization of a dromedary with bovine erythrocyte carbonic anhydrase and porcine pancreatic alpha-amylase, it was demonstrated that a considerable amount of heavy-chain antibodies, acting as true competitive inhibitors, circulate in the bloodstream. In contrast, the conventional antibodies apparently do not interact with the enzyme's active site. Next we illustrated that peripheral blood lymphocytes are suitable for one-step cloning of the variable domain fragments in a phage-display vector. By bio-panning, several antigen-specific single-domain fragments are readily isolated for both enzymes. In addition we show that among those isolated fragments active site binders are well represented. When produced as recombinant protein in Escherichia coli, these active site binders appear to be potent enzyme inhibitors when tested in chromogenic assays. The low complexity of the antigen-binding site of these single-domain antibodies composed of only three loops could be valuable for designing smaller synthetic inhibitors
Publication date
LanguageEnglish
AffiliationNRC Institute for Biological Sciences; National Research Council Canada
Peer reviewedNo
NRC numberLAUWEREYS1998
NPARC number9385901
Export citationExport as RIS
Report a correctionReport a correction
Record identifier6343c7a0-8bb5-421a-9af1-6f96ddf3ee21
Record created2009-07-10
Record modified2016-05-09
Bookmark and share
  • Share this page with Facebook (Opens in a new window)
  • Share this page with Twitter (Opens in a new window)
  • Share this page with Google+ (Opens in a new window)
  • Share this page with Delicious (Opens in a new window)